ARCHIVES

FDA News: FDA Eases Two-Trial Standard For Proof Of Drug Efficacy

This article is from The Cancer Letter archive.

Vol. 23 No. 11 | March 21, 1997

Download PDF Visit The Full Archive

Related Articles

FDA Authority To Regulate Off-Label Promotion Challenged In Federal Court.

January 15, 2010

Cervical Cancer Screening Can Be Done Later, Less Often

December 25, 2009

Evidence Reported That Silica Increase Risk Of Cancer

September 7, 1984

Power’s Offer to Write Report On NCAB’s Organ Systems Decision Declined By DeVita

June 15, 1984

ODAC Votes Against Adria’s Chemoprotector, Okays Leustatin

July 3, 1992

House Science Committee Chairman Questions NIH Budget Increases.

February 2, 2001